Efficacy and Safety of Daprodustat for Anemia Therapy in Chronic Kidney Disease Patients: A Systematic Review and Meta-Analysis

Objective: Daprodustat is a novel oral agent in treating anemia of chronic kidney disease (CKD), and several clinical trials have been conducted to compare daprodustat with recombinant human erythropoietin (rhEPO) or placebo. Our systematic review aimed to investigate the efficacy and safety of dapr...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Qiyan, Wang, Yahui, Yang, Huisheng, Sun, Luying, Fu, Xinwen, Wei, Ruojun, Liu, Yu Ning, Liu, Wei Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7883598/
https://www.ncbi.nlm.nih.gov/pubmed/33597868
http://dx.doi.org/10.3389/fphar.2020.573645

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7883598/
https://www.ncbi.nlm.nih.gov/pubmed/33597868
http://dx.doi.org/10.3389/fphar.2020.573645

Ejemplares similares